Millions of Americans will have a hard time falling or staying asleep tonight, and research says most of them will be women. “Insomnia is definitely more common in females, and it seems to begin fairly early on,” said Dr. Meir Kryger, a professor at the Yale School of Medicine who studies sleep. Sleep problems can appear in women as early as their teens or 20s, he said. Various research shows women are more likely than men to experience the sleep disorder. Women are about 1.5 times more likely to have insomnia, said Kryger, who has written several books on the topic, including “The Mystery of Sleep,” which was published in March.
In 1776, Abigail Adams asked her husband to “remember the ladies.”
Oh, if only Melania were so moved. Donald Trump could use the reminder. From the moment he announced his improbable campaign, Trump has played to his most conservative supporters by promising to severely restrict abortion rights, as well as limit access to affordable birth control. The battle has settled onto two fronts, including defunding Planned Parenthood, and—since a “repeal and replace effort” fell short—removing from the Affordable Care Act the mandate that requires employers to provide insurance coverage for contraceptives to their eligible workers. On the first front, Connecticut has vowed to fund Planned Parenthood, should the federal government pull away.
A genetic test that helps doctors determine how best to treat breast cancer—and whether chemotherapy is likely to help—is significantly more likely to be administered to white women than blacks or Hispanics, a Yale study has found. The test, called Oncotype Dx (ODx), uses gene expression to gauge how early-stage breast cancer is affecting patients’ gene activity. It uses the information to determine how likely cancer recurrence would be, and physicians and their patients can use that knowledge to decide how to proceed with treatment. Yale researchers retrospectively analyzed a group of more than 8,000 Connecticut women who were diagnosed with hormone receptor positive breast cancer between 2011 and 2013, and found “significant racial and ethnic disparities in use of this new gene test,” said study leader Dr. Cary Gross, a member of Yale Cancer Center and professor of medicine and epidemiology at Yale School of Medicine. “It reinforces that, at the same time we are investing in developing new treatments and new testing strategies and we’re promoting them with great excitement, we really need to double-down our efforts to eliminate disparity,” Gross said.
Low-income women in Connecticut who have just given birth and know they don’t want to get pregnant again anytime soon are now offered a long-acting birth control option postpartum. Medical providers say the policy by the U.S. Department of Health and Human Services will reduce the number of unplanned pregnancies, as well as lead to better maternal health outcomes by ensuring pregnancies are spaced a healthy length of time apart. Connecticut’s HUSKY program is one of 26 state Medicaid programs nationwide that reimburses hospitals for administering long-acting reversible contraception (LARC)—namely, intrauterine devices (IUDs) and subdermal implants—to Medicaid patients. HUSKY started reimbursing for the devices last year. “It’s a great thing,” said Dr. Elizabeth Purcell, an obstetrician and gynecologist practicing in Hartford.
A growing number of women are getting hurt by falling, and they are much more likely to suffer fall-related injuries than men, data show. From 2011 to 2014, 51 women per 1,000 population were hurt in falls, up from 47 per 1,000 from 2005 to 2008, according to recent data from the National Center for Health Statistics and the Centers for Disease Control and Prevention (CDC). Falls were the most common cause of nonfatal injuries to women, the report found, and significantly outpaced injuries from overexertion, the second leading cause of injury that afflicted just 14 per 1,000.
Hormone-related changes associated with menopause are the main reasons women are so prone to falling, especially as they age, said Dr. Karen Sutton, an orthopaedic surgeon, director of Women’s Sports Medicine at Yale New Haven Hospital, and associate professor of orthopaedics and rehabilitation at the Yale School of Medicine. “Their muscles are weaker, their bones are weaker,” she said, since hormone changes lead to reduced bone mass and the onset of osteoporosis in many women.
Now that America has elected Donald J. Trump as their 45th president, how might the New York entrepreneur’s administration affect women and children in the next few years? Some of this is pure conjecture, since Trump’s policy talks have been notably short on details. Trump has, however, repeatedly said he intends to repeal most of the Affordable Care Act, or Obamacare, which would have grave effect on hundreds of thousands of families, if not more. Since 2010, the ACA has cut in half the number of uninsured citizens to a historic low of 8.6 percent of citizens, or 27.3 million people . A 2015 Congressional Budget Office study said that repealing the program would eliminate insurance coverage for about 22 million in 2017, and coverage of birth control and critical prenatal care might no longer be offered.
Women who spend many years working long hours have significantly higher chances of developing heart disease, cancer and other chronic diseases, according to new research. The study found that women who worked more than 60 hours per week were nearly three times more likely to develop heart disease, non-skin cancers, arthritis and diabetes than those who worked less. Researchers at the Center for HOPES at Ohio State University’s College of Public Health and the Center for the Science of Health Care Delivery at Mayo Clinic conducted the research. Even among women who worked fewer than 60 hours per week, the odds of developing the chronic ailments grew as women’s work hours increased, according to the study—a trend that did not hold true for men. Men who worked longer hours had an increased risk only of developing arthritis, and actually had a decreased risk of heart disease when they worked “moderately long hours” of 41 to 50 hours per week.
Now is the time to repeal a 40-year-old law that perpetuates inequality among women. The Hyde Amendment, which bans the use of federal funds to pay for abortions except in certain circumstances, is unfair. The amendment targets women who rely on Medicaid for their health care coverage. According to the federal Centers for Medicare and Medicaid Services, roughly two out of three adult women enrolled in Medicaid are between the ages of 19 and 44—the reproductive years. Abortions can run upward of $1,000, which places the (legal) procedure out of reach for most women living in poverty.
The Senate voted unanimously Wednesday night to send a bill requiring private insurance companies to cover 3D mammography to Gov. Dannel P. Malloy’s desk. Sen. Joe Crisco, D-Woodbridge, whose wife is currently going through breast cancer treatments, fought back tears as he talked about how his wife had annual mammograms and checkups every four months, and yet has been fighting breast cancer for two months now. “Chemotherapy treatments, surgery, and now she faces 12 sessions of radiation,” Crisco said. “This new technology is offering new opportunities for physicians to diagnose breast cancer in women and provide life saving treatments earlier than ever.”
To read the full story by Christine Stuart of ctnewsjunkie.com click here.
Several times every month, protesters come to the New Haven Planned Parenthood of Southern New England office to hold signs and pray the rosary. Planned Parenthood serves about 64,000 Connecticut patients a year, though according to a recent annual report, abortions are only about six percent of its services. Most of the services revolve around providing contraceptive services and testing for sexually transmitted diseases. Last month, the federal Food and Drug Administration eased restrictions on the so-called abortion pill, also known as RU-486. The new rules allow women to use the drug later in their pregnancies with less visits to the doctor.